New stock on the first day | Tianxing Medical (01609) listed for the first time with a high open of 192.39% in the morning. The company is a domestic provider of sports medical implants and devices.

Tianxing Medical (01609) made its debut on the stock market, with an announcement showing that each share was priced at 98.5 Hong Kong dollars. A total of 8.4219 million shares were issued, with a minimum subscription of 50 shares per lot, resulting in a net proceeds of approximately 7.584 billion Hong Kong dollars. It is worth mentioning that the stock received 300,700 applications from the public in Hong Kong, with 16,800 accepted, oversubscribed by 7823.13 times. As of the time of writing, the stock has risen by 192.39%, trading at 288 Hong Kong dollars with a turnover of 4.58 billion Hong Kong dollars. Public information shows that Tianxing Medical is a leading provider of comprehensive solutions in sports medicine in China, focusing on the research, development, production, and commercialization of sports medicine implants, surgical equipment, and related consumables. The company's products are mainly used for the repair and reconstruction of soft tissue injuries in joints such as shoulders, knees, hips, and ankles, and also provide comprehensive solutions for sports rehabilitation and prevention. According to data from Zhoushi Consulting, based on 2024 sales revenue, Tianxing Medical is the fourth largest sports medicine implant and equipment supplier in China and the largest domestic supplier with a market share of 6.5%. In terms of performance, the company's revenue and net profit attributable to shareholders are expected to reach 403 million and 137 million respectively by 2025.